Afuco™ Anti-Human CA215 ADCC Therapeutic Antibody, ADCC Enhanced
Anti-CA215 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The humanization of RP215 monoclonal antibody which is of murine origin, known to recognize specifically a carbohydrate-associated epitope of cancer cell-expressed glycoproteins, known as CA215. The primary structure of the humanized forms of RP215 can then be utilized for the therapeutic treatment of human cancers as antibody-based anticancer drugs.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-083CL |
| Pricing | Inquiry |
| Host | Humanized |
| Target | CA215 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Store at –20 or -70°C upon receipt. Divide antibody into aliquots prior usage and avoid multiple freeze-thaw cycles. |